Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Up 346.7% in August

Straumann Holding AG (OTCMKTS:SAUHY) was the target of a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 4,471 shares, an increase of 346.7% from the August 15th total of 1,001 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 81,714 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Straumann from a “buy” rating to a “hold” rating in a report on Friday, August 21st. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. Barclays reiterated an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Citigroup restated a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. Finally, BMO Capital Markets started coverage on Straumann in a report on Wednesday, July 8th. They issued an “outperform” rating on the stock. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold”.

Straumann Trading Up 0.1%

Shares of SAUHY stock traded up $0.01 during mid-day trading on Friday, reaching $11.47. The company’s stock had a trading volume of 80,295 shares, compared to its average volume of 46,263. The firm’s 50-day moving average is $12.19 and its two-hundred day moving average is $11.61. Straumann has a 1-year low of $9.44 and a 1-year high of $13.61.

Straumann Company Profile

Straumann Group is a Switzerland-based dental technology company that develops, manufactures and distributes products used in implant, restorative and orthodontic dentistry. Its portfolio includes dental implants, prosthetic components, biomaterials, digital dentistry systems, clear aligners and related instruments and services.

The company serves dental professionals, laboratories and patients through brands including Straumann, Neodent, ClearCorrect and Medentika. Its solutions are used in tooth replacement, oral tissue regeneration, orthodontic treatment and digitally integrated dental workflows.

Founded in 1954, Straumann has expanded from its Swiss origins into a global business serving customers across Europe, North America, Latin America, Asia-Pacific and other international markets.